Galera Therapeutics, Inc. ($GRTX)
Filing Information
| Accession Number | 0001193125-26-335224 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
709,884
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 15, 2026 | Conversion | 661,309 | โ | โ | 9,486,852 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 3, 2026 | Sale to Issuer | 47,434 | โ | โ | 0 | Direct | โ | View Details | |
Director | Series B Preferred Stock | Derivative | May 15, 2026 | Conversion | 661 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 3, 2026 | Sale to Issuer | 480 | โ | โ | 0 | Direct | โ | View Details |